Syncom Formulations is trading at ₹24.72, down 5.58%, with no confirmed company-specific news identified to explain the September 30 decline.
- Its 38th AGM was scheduled for September 30; director appointments and a proposed dividend were on the agenda, but available reporting does not link them to the move.
- Shares had risen sharply in the two preceding sessions, which alone does not establish why they fell. September 30 trading activity or volume was not confirmed.